Skip to content

US · BFLY · MEDICAL - DEVICES

Butterfly Network, Inc. (BFLY) intrinsic value and stock valuation

$5.40as of 2026-11-21 · Mkt cap 2.24B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Butterfly Network, Inc. DCF and intrinsic value

InvestorsCraft values BFLY with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from BFLY’s statements →

Butterfly Network, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Burlington, MA 01803 butterflynetwork.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$97.6M+16.1% 5y CAGRd
20182025
Net income
-$-77.06M
20182025
Free cash flow
-$-16.05M
20182025
Total equity
$196M
20182025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$97.6M$82.1M$65.9M$73.4M$62.6M
Operating income-$-86.42M-$-74.41M-$-145.61M-$-193.02M-$-192.73M
Net income-$-77.06M-$-72.49M-$-133.7M-$-168.72M-$-32.41M
EPSd-$-311.83K-$-342.45K-$-650.96K-$-844.23K-$-186.47K
Operating cash flow-$-12.7M-$-41.71M-$-98.82M-$-169.12M-$-189.19M
Capital expenditure-$-3.35M-$-2.69M-$-5.78M-$-18.3M-$-7.88M
Free cash flow-$-16.05M-$-44.4M-$-104.6M-$-187.42M-$-197.06M
Total assets$296.5M$256.1M$304.3M$417.6M$572M
Total debt$20.4M$22.8M$25M$31.9M$29.1M
Net debt-$-130.09M-$-65.94M-$-109.61M-$-130.67M-$-393.76M
Total equity$196M$168.8M$220.1M$325.4M$447.7M
Cash and short-term investments$150.5M$88.8M$134.6M$237.8M$422.8M
Income statement
20252024202320222021
Revenue$97.6M$82.1M$65.9M$73.4M$62.6M
Cost of revenue$51.9M$33.2M$49M$33.9M$45.5M
Gross profit$45.7M$48.8M$16.9M$39.5M$17.1M
Research and development expenses$36.3M$37.8M$55.6M$88M$74.5M
Selling, general and administrative expenses$85.1M$85.4M$106.9M$144.4M$135.3M
Other expenses$10.8M$0.00$0.00$0.00$0.00
Operating expenses$132.2M$123.2M$162.5M$232.5M$209.8M
Cost and expenses$184M$156.5M$211.5M$266.4M$255.3M
Interest income$5.91M$5.02M$7.45M$3.38M$2.57M
Interest expense$1.49M$1.26M$0.00$0.00$650K
Depreciation and amortization$8.08M$10.3M$10.6M$5.93M$2.09M
Ebitda-$-67.38M-$-60.92M-$-123.04M-$-162.74M-$-29.55M
Operating income-$-86.42M-$-74.41M-$-145.61M-$-193.02M-$-192.73M
Total other income/expenses, net$9.46M$1.89M$12M$24.3M$160.4M
Income before tax-$-76.95M-$-72.52M-$-133.62M-$-168.68M-$-32.29M
Income tax expense$110K-$-30K$80K$40K$120K
Net income-$-77.06M-$-72.49M-$-133.7M-$-168.72M-$-32.41M
Weighted average shares outstanding$247.1M$211.7M$205.4M$199.9M$173.8M
Weighted average diluted shares outstanding$247.1M$211.7M$205.4M$199.9M$173.8M
Balance sheet
20252024202320222021
Cash and short-term investments$150.5M$88.8M$134.6M$237.8M$422.8M
Net receivables$26.7M$20.8M$13.4M$14.7M$11.9M
Inventory$61.4M$70.8M$73M$60M$36.2M
Total current assets$249.1M$192.6M$231.3M$357.1M$511.9M
Property, plant and equipment, net$29.2M$33.8M$41M$52.9M$38.8M
Goodwill and intangible assets$7.52M$8.92M$10.3M$0.00$0.00
Long-term investments$4.01M$4.01M$4.01M$4.01M$4M
Total non-current assets$47.4M$63.5M$73M$60.4M$60.1M
Total assets$296.5M$256.1M$304.3M$417.6M$572M
Accounts payable$5.44M$4.25M$5.09M$7.21M$5.8M
Short-term debt$2.68M$2.44M$2.19M$1.93M$1.39M
Deferred revenue$26.9M$16.1M$15.6M$15.9M$13.1M
Total current liabilities$65.1M$48.2M$44.3M$51.3M$49.8M
Long-term debt$17.7M$20.4M$22.8M$30M$27.7M
Deferred revenue, non-current$9.39M$7.32M$7.39M$4.96M$5.48M
Total non-current liabilities$35.4M$39M$40M$40.9M$74.4M
Capital lease obligations$2.68M$20.4M$22.8M$30M$27.7M
Total liabilities$100.6M$87.3M$84.2M$92.2M$124.3M
Common stock$30K$20K$20K$20K$20K
Retained earnings-$-879.19M-$-802.13M-$-729.64M-$-595.94M-$-427.21M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$196M$168.8M$220.1M$325.4M$447.7M
Total investments$4.01M$4.01M$4.01M$79.3M$4M
Total debt$20.4M$22.8M$25M$31.9M$29.1M
Net debt-$-130.09M-$-65.94M-$-109.61M-$-130.67M-$-393.76M
Cash flow statement
20252024202320222021
Net income-$-77.06M-$-72.49M-$-133.7M-$-168.72M-$-32.41M
Depreciation and amortization$8.08M$10.3M$10.6M$5.93M$2.09M
Stock-based compensation$23.4M$21M$27.5M$42.5M$47.8M
Change in working capital$15.2M-$-4.82M-$-20.13M-$-29.4M-$-51.05M
Accounts receivable-$-6.75M-$-8.5M-$-160K-$-3.06M-$-6.13M
Inventory$1.43M$2.22M-$-34.13M-$-24.51M-$-11.29M
Accounts payable$5.09M-$-840K-$-1.88M$1.22M-$-10.52M
Net cash provided by operating activities-$-12.7M-$-41.71M-$-98.82M-$-169.12M-$-189.19M
Investments in property, plant and equipment-$-3.35M-$-2.69M-$-5.78M-$-18.3M-$-7.88M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-3.35M-$-2.66M$70.4M-$-93.78M-$-9.87M
Common stock issued$2.23M$0.00$0.00$0.00$548.4M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$77.8M-$-1.5M$230K$2.88M$565.7M
Net change in cash$61.7M-$-45.86M-$-28.18M-$-260.01M$366.6M
Cash at end of period$154.5M$92.8M$138.7M$166.8M$426.8M
Operating cash flow-$-12.7M-$-41.71M-$-98.82M-$-169.12M-$-189.19M
Capital expenditure-$-3.35M-$-2.69M-$-5.78M-$-18.3M-$-7.88M
Free cash flow-$-16.05M-$-44.4M-$-104.6M-$-187.42M-$-197.06M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Butterfly Network, Inc.

        Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.

        CEO
        Joseph DeVivo
        Employees
        220
        Beta
        2.05

        Explore

        Frequently asked questions

        What is the intrinsic value of Butterfly Network, Inc. (BFLY)?

        Butterfly Network, Inc. (BFLY) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is BFLY undervalued?

        BFLY trades at a price of $5.40 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.